
浏览全部资源
扫码关注微信
海军军医大学第二附属医院神经内科,上海 200003
[ "陈晓晗,Email:1064418472@qq.com,研究方向:脑血管病、认知、睡眠。" ]
尹又,主任医师,硕导,上海市医学会神经病学分会青年副主任委员、上海市医学会痴呆与认知功能障碍学组副组长、上海市医师协会神经病学分会委员;申请国际、国防、国家发明、实用新型等专利24项;发表国内外学术论文70余篇,其中SCI论文第一/通信作者13篇;发表教学论文9篇。获中国睡眠医学第九届学术会议优秀论文二等奖、获《临床医学研究与实践杂志》2017/2019医学科技成果一等奖。Email:yinyou19@163.com。
纸质出版日期:2021-11-28,
收稿日期:2021-07-03,
扫 描 看 全 文
陈晓晗, 龚宝峰, 褚坚坚, 等. 脑小血管病患者认知、睡眠和血浆标志物的研究进展[J]. 重庆医科大学学报, 2021,46(11):1342-1347.
Xiaohan Chen, Baofeng Gong, Jianjian Chu, et al. Research progress of cognition, sleep and plasma biomarkers in patients with cerebral small vessel disease[J]. Journal of Shanxi Agricultural Sciences, 2021,46(11):1342-1347.
陈晓晗, 龚宝峰, 褚坚坚, 等. 脑小血管病患者认知、睡眠和血浆标志物的研究进展[J]. 重庆医科大学学报, 2021,46(11):1342-1347. DOI: 10.13406/j.cnki.cyxb.002915.
Xiaohan Chen, Baofeng Gong, Jianjian Chu, et al. Research progress of cognition, sleep and plasma biomarkers in patients with cerebral small vessel disease[J]. Journal of Shanxi Agricultural Sciences, 2021,46(11):1342-1347. DOI: 10.13406/j.cnki.cyxb.002915.
近年来随着神经影像技术的提高与普及,越来越多的脑小血管病被正确识别,脑小血管病在老年人群中已经成为一类常见病。脑小血管病能够引起一系列威胁患者健康的问题,尤其是认知功能损害,但由于疾病早期症状不突出,影像学检查滞后等原因,目前临床仍然缺乏有效的手段尽早识别此类疾病。本文阐述了脑小血管病的影像分型以及其特征性认知功能改变,探讨睡眠和血浆生物标志物与脑小血管病之间的关系,为临床早期鉴别诊断和个体化治疗提供有力依据。
In recent years
with the improvement and popularization of neuroimaging technology
more and more cases of cerebral small vessel disease (CSVD) have been correctly identified
and it has become a common disease among the elderly. CSVD can cause a series of problems threatening patients'health
especially cognitive impairment. However
due to the lack of prominent early symptoms and lagging imaging examination
there is still a lack of effective means to identify such diseases as soon as possible. This paper expounds the imaging classification of CSVD and its characteristic cognitive function changes
and discusses its relationship between sleep and plasma biomarkers
so as to provide a strong basis for early clinical differential diagnosis and individualized treatment.
脑小血管病影像分型认知功能睡眠血浆生物标志物
cerebral small vessel diseaseimaging classificationcognitive functionsleepplasma biomarkers
Mustapha M, Nassir CMNCM, Aminuddin N, et al. Cerebral small vessel disease(CSVD): lessons from the animal models[J]. Front Physiol, 2019, 10:1317.
Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review[J]. Neurology, 2019, 92(24):1146-1156.
Okazaki S, Hornberger E, Griebe M, et al. MRI characteristics of the evolution of supratentorial recent small subcortical infarcts[J]. Front Neurol, 2015, 6:118.
Pinter D, Gattringer T, Enzinger C, et al. Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors[J]. J Cereb Blood Flow Metab, 2019, 39(9):1669-1677.
Moreau F, Patel S, Lauzon ML, et al. Cavitation after acute symptomatic lacunar stroke depends on time, location, and MRI sequence[J]. Stroke, 2012, 43(7):1837-1842.
Kwon HS, Cho AH, Lee MH, et al. Evolution of acute lacunar lesions in terms of size and shape: a PICASSO sub-study[J]. J Neurol, 2019, 266(3):766-772.
de Silva TM, Miller AA. Cerebral small vessel disease: targeting oxidative stress as a novel therapeutic strategy?[J]. Front Pharmacol, 2016, 7:61.
Li Q, Yang Y, Reis C, et al. Cerebral small vessel disease[J]. Cell Transplant, 2018, 27(12):1711-1722.
Zeng WY, Chen YT, Zhu ZB, et al. Severity of white matter hyperintensities: lesion patterns, cognition, and microstructural changes[J]. J Cereb Blood Flow Metab, 2020, 40(12):2454-2463.
Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral microbleeds: imaging and clinical significance[J]. Radiology, 2018, 287(1):11-28.
Shi YL, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease[J]. Stroke Vasc Neurol, 2016, 1(3):83-92.
Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patientswithspontaneousintracerebralhemorrhage: evidenceof microangiopathy-related microbleeds[J]. AJNR Am J Neuroradiol, 1999, 20(4):637-642.
Riba-Llena I, Nafría C, Mundet X, et al. Assessment of enlarged perivascular spaces and their relation to target organ damage and mild cognitive impairment in patients with hypertension[J]. Eur J Neurol, 2016, 23(6):1044-1050.
Jiang YF, Wang YZ, Yuan ZY, et al. Total cerebral small vessel disease burden is related to worse performance on the mini-mental state examination and incident dementia: a prospective 5-year follow-up[J]. J Alzheimers Dis, 2019, 69(1):253-262.
Uiterwijk R, Staals J, Huijts M, et al. MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension[J]. J Hypertens, 2017, 35(6):1263-1270.
Burton EJ, Kenny RA, O'Brien J, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients[J]. Stroke, 2004, 35(6):1270-1275.
Tubi MA, Feingold FW, Kothapalli D, et al. White matter hyperintensities and their relationship to cognition: effects of segmentation algorithm[J]. Neuroimage, 2020, 206:116327.
Lambert C, Benjamin P, Zeestraten E, et al. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease[J]. Brain, 2016, 139(Pt 4):1136-1151.
Chen X, Huang LL, Ye Q, et al. Disrupted functional and structural connectivity within default mode network contribute to WMH-related cognitive impairment[J]. Neuroimage Clin, 2019, 24:102088.
Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI[J]. Brain, 2004, 127(Pt 10):2265-2275.
Chung CP, Chou KH, Chen WT, et al. Strictly lobar cerebral microbleeds are associated with cognitive impairment[J]. Stroke, 2016, 47(10):2497-2502.
Ding J, Siguresson S, Jónsson PV, et al. Space and location of cerebral microbleeds, cognitive decline, and dementia in the community[J]. Neurology, 2017, 88(22):2089-2097.
Arba F, Quinn TJ, Hankey GJ, et al. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack[J]. Int J Stroke, 2018, 13(1):47-56.
Ding J, Siguresson S, Jónsson PV, et al. Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, andriskofdementia: theage, gene/environment susceptibility-reykjavik study[J]. JAMA Neurol, 2017, 74(9):1105-1112.
Wang JH, Chen XD, Liao JC, et al. The influence of nonbreathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease[J]. Neuropsychiatr Dis Treat, 2019, 15:1009-1014.
Wang JH, Chen XD, Liao JC, et al. Non breathing-related sleep fragmentation and imaging markers in patients with atherosclerotic cerebral small vessel disease(CSVD): a cross-sectional case-control study[J]. BMC Neurol, 2020, 20(1):98.
del Brutto OH, Mera RM, del Brutto VJ, et al. Enlarged basal Ganglia perivascular spaces and sleep parameters. A population-based study[J]. Clin Neurol Neurosurg, 2019, 182:53-57.
Qiu MH, Vetrivelan R, Fuller PM, et al. Basal Ganglia control of sleep-wake behavior and cortical activation[J]. Eur J Neurosci, 2010, 31(3):499-507.
Albrecht U, Ripperger JA. Circadian clocks and sleep: impact of rhythmic metabolism and waste clearance on the brain[J]. Trends Neurosci, 2018, 41(10):677-688.
Del Brutto OH, Mera RM, Zambrano M, et al. Relationship between obstructive sleep apnea and neuroimaging signatures of cerebral small vessel disease in community-dwelling older adults. The Atahualpa Project[J]. Sleep Med, 2017, 37:10-12.
Koo DL, Kim JY, Lim JS, et al. Cerebral microbleeds on MRI in patients with obstructive sleep apnea[J]. J Clin Sleep Med, 2017, 13(1):65-72.
Song TJ, Park JH, Choi KH, et al. Moderate-to-severe obstructive sleep apnea is associated with cerebralsmallvesseldisease[J]. Sleep Med, 2017, 30:36-42.
Moon J, Choi KH, Park JH, et al. Sympathetic overactivity based on heart-rate variability in patients with obstructive sleep apnea and cerebral small-vessel disease[J]. J Clin Neurol, 2018, 14(3):310-319.
Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea[J]. Trends Cardiovasc Med, 2008, 18(7):253-260.
Grinberg LT, Thal DR. Vascular pathology in the aged human brain[J]. Acta Neuropathol, 2010, 119(3):277-290.
Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a Meta-review[J]. Respirology, 2013, 18(1):61-70.
Wallace A, Bucks RS. Memory and obstructive sleep apnea: a Meta-analysis[J]. Sleep, 2013, 36(2):203-220.
Ramos AR, Tarraf W, Rundek T, et al. Obstructive sleep apnea and neurocognitive function in a Hispanic/Latino population[J]. Neurology, 2015, 84(4):391-398.
Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location[J]. Neurology, 2004, 63(2):246-253.
Feng J, Wu Q, Zhang D, et al. Hippocampal impairments are associated with intermittent hypoxia of obstructive sleep apnea[J]. Chin Med J(Engl), 2012, 125(4):696-701.
Charidimou A, Boulouis G, Gurol ME, et al. Emerging concepts in sporadic cerebral amyloid angiopathy[J]. Brain, 2017, 140(7):1829-1850.
Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, et al. White matter hyperintensities: relationship to amyloid and tau burden[J]. Brain, 2019, 142(8):2483-2491.
Romero JR, Demissie S, Beiser A, et al. Relation of plasma β-amyloid, clusterin, and tau with cerebral microbleeds: Framingham heart study[J]. Ann Clin Transl Neurol, 2020, 7(7):1083-1091.
Weingarten MD, Lockwood AH, Hwo SY, et al. A protein factor essential for microtubule assembly[J]. PNAS, 1975, 72(5):1858-1862.
Kim HJ, Park S, Cho H, et al. Assessment of extent and role of tau in subcortical vascular cognitive impairment using 18F-AV1451 positron emission tomography imaging[J]. JAMA Neurol, 2018, 75(8):999-1007.
Barro C, Benkert P, Disanto G, et al. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis[J]. Brain, 2018, 141(8):2382-2391.
Brureau A, Blanchard-Bregeon V, Pech C, et al. NFL in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration[J]. Neurobiol Dis, 2017, 104:73-84.
Kuhle J, Barro C, Disanto G, et al. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity[J]. Mult Scler, 2016, 22(12):1550-1559.
Gattringer T, Pinter D, Enzinger C, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease[J]. Neurology, 2017, 89(20):2108-2114.
Janelidze S, Mattsson N, Palmqvist S, et al. Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia[J]. Nat Med, 2020, 26(3):379-386.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621